New guidance targets dangerous ‘rhino tranq’ withdrawal
November 18, 2026
The University of Cincinnati's M. Ross Lawson and Richard Ryan spoke with Medscape about new American Society of Addiction Medicine clinical guidance on managing intoxication and potentially life-threatening complications from withdrawal associated with medetomidine, also known as “rhino tranq.”